Manila offers Covid-19 treatment drug for free

    Presidential aspirant and Manila City Mayor Francisco “Isko Moreno” Domagoso said the city of Manila is offering the antiviral drug for free.
    He announced that the city government received around 40, 000 Molnupiravir capsules that are already purchased and will be given for free to COVID-19 patients.

    METRO MANILA, Philippines — The local government said that the first batch was delivered to the Sta. Ana Hospital in Manila due to the sufficient storage space there while several boxes were also delivered to the Luneta-based Manila COVID-19 Field Hospital.

    In order for the patient to claim the free pills, he or she should present a doctor’s prescription for the medicine, a positive RT-PCR test result, and a photocopy of the patient’s valid identification or, if applicable, the valid identification of a representative.

    The city would also like to accommodate patients residing outside of Manila but wants to get the pill for free.

    The drug is said to be effective against mild or moderate COVID-19 cases and reportedly reduces risk of hospitalization and death of COVID-19 by around 50 percent.

    The drug is still being evaluated by the Food and Drug Administration (FDA) for emergency use; however, Moreno said that FDA granted Manila a Compassionate Special Permit (CSP). It is not yet commercially available in the country and it is far accessible through a special permit to at least 30 hospitals nationwide.

    The free Molnupiravir capsules can be claimed at six Manila district hospitals namely Sta. Ana Hospital; Ospital ng Maynila; Gat Andres Bonifacio; Justice Jose Abad Santos; Ospital ng Sampaloc; and Ospital ng Tondo.

    Aside from the free Molnupiravir pills that Manila offers, it is also available through Vice President Leni Robredo’s E-Konsulta platform due to a memorandum agreement with QualiMed Health Network.

    The Philippines is taking part in a worldwide trial of the new antiviral medication. Early trials revealed that it might cut the risk of dying or being hospitalized in COVID-19 individuals who were at high risk of serious illness in half. The Asian Hospital and Medical Center, as well as Quirino Medical Center, will host the country’s third Phase Clinical Trial for the pill. (JE/The MiNT)

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here